{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:16:20Z","timestamp":1791591380163,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2404603, 2022YFC2404600"],"award-info":[{"award-number":["2022YFC2404603, 2022YFC2404600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12375339, 11675042"],"award-info":[{"award-number":["12375339, 11675042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02677-w","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T12:37:24Z","timestamp":1749904644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Beyond the ratio of tumor reduction: residual volume after induction chemotherapy emerges as the optimal biomarker in advanced nasopharyngeal cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Sixue","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"10192","key":"2677_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"Y-P Chen","year":"2019","unstructured":"Chen Y-P, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380.","journal-title":"Lancet"},{"issue":"16","key":"2677_CR2","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1002\/cncr.25932","volume":"117","author":"X An","year":"2011","unstructured":"An X, et al. Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic\/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy. Cancer. 2011;117(16):3750\u20137.","journal-title":"Cancer"},{"key":"2677_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1200\/EDBK_280747","volume":"40","author":"BB Ma","year":"2020","unstructured":"Ma BB, et al. Recent advances in the development of biomarkers and chemoradiotherapeutic approaches for nasopharyngeal carcinoma. Am Soc Clin Oncol Educational Book. 2020;40:270\u201380.","journal-title":"Am Soc Clin Oncol Educational Book"},{"issue":"11","key":"2677_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","volume":"17","author":"Y Sun","year":"2016","unstructured":"Sun Y, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol. 2016;17(11):1509\u201320.","journal-title":"Lancet Oncol"},{"issue":"8","key":"2677_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1158\/1078-0432.CCR-17-2656","volume":"24","author":"Y-P Chen","year":"2018","unstructured":"Chen Y-P, et al. Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials. Clin Cancer Res. 2018;24(8):1824\u201333.","journal-title":"Clin Cancer Res"},{"key":"2677_CR6","doi-asserted-by":"publisher","first-page":"24835","DOI":"10.1038\/srep24835","volume":"6","author":"H Peng","year":"2016","unstructured":"Peng H, et al. The tumour response to induction chemotherapy has prognostic value for Long-Term survival outcomes after Intensity-Modulated radiation therapy in nasopharyngeal carcinoma. Sci Rep. 2016;6:24835.","journal-title":"Sci Rep"},{"issue":"2","key":"2677_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijrobp.2019.01.007","volume":"104","author":"C-L Huang","year":"2019","unstructured":"Huang C-L, et al. Plasma Epstein-Barr virus DNA load after induction chemotherapy predicts outcome in locoregionally advanced nasopharyngeal carcinoma. Int J Radiation Oncology*Biology*Physics. 2019;104(2):355\u201361.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"1","key":"2677_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12885-015-1288-8","volume":"15","author":"Y Chen","year":"2015","unstructured":"Chen Y, et al. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy? BMC Cancer. 2015;15(1):305.","journal-title":"BMC Cancer"},{"issue":"1","key":"2677_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/1471-2407-13-260","volume":"13","author":"S-B Liang","year":"2013","unstructured":"Liang S-B, et al. Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma. BMC Cancer. 2013;13(1):260.","journal-title":"BMC Cancer"},{"issue":"3","key":"2677_CR10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1148\/radiol.13122607","volume":"269","author":"RA Schoot","year":"2013","unstructured":"Schoot RA, et al. Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments? Radiology. 2013;269(3):870\u20138.","journal-title":"Radiology"},{"issue":"3","key":"2677_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1148\/radiol.2016151301","volume":"280","author":"M Aghighi","year":"2016","unstructured":"Aghighi M, et al. Three-dimensional radiologic assessment of chemotherapy response in ewing sarcoma can be used to predict clinical outcome. Radiology. 2016;280(3):905\u201315.","journal-title":"Radiology"},{"key":"2677_CR12","doi-asserted-by":"crossref","unstructured":"Kwong TSA et al. Volumetric measurement to evaluate treatment response to induction chemotherapy on MRI outperformed RECIST guideline in outcome prediction in advanced nasopharyngeal carcinoma. ESMO Open. 2024;9(10).","DOI":"10.1016\/j.esmoop.2024.103933"},{"issue":"1","key":"2677_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijrobp.2007.02.032","volume":"69","author":"AD King","year":"2007","unstructured":"King AD, et al. Nasopharyngeal cancers: which method should be used to measure these irregularly shaped tumors on cross-sectional imaging? Int J Radiat Oncol Biol Phys. 2007;69(1):148\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2677_CR14","doi-asserted-by":"publisher","first-page":"104924","DOI":"10.1016\/j.oraloncology.2020.104924","volume":"111","author":"Y-Y Zeng","year":"2020","unstructured":"Zeng Y-Y, et al. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Oral Oncol. 2020;111:104924.","journal-title":"Oral Oncol"},{"issue":"40","key":"2677_CR15","doi-asserted-by":"publisher","first-page":"eadf0837","DOI":"10.1126\/sciadv.adf0837","volume":"9","author":"GH Su","year":"2023","unstructured":"Su GH, et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Sci Adv. 2023;9(40):eadf0837.","journal-title":"Sci Adv"},{"issue":"1","key":"2677_CR16","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1038\/s41467-024-47541-9","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Tumor phylogeography reveals block-shaped Spatial heterogeneity and the mode of evolution in hepatocellular carcinoma. Nat Commun. 2024;15(1):3169.","journal-title":"Nat Commun"},{"issue":"11","key":"2677_CR17","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.2967\/jnumed.111.092767","volume":"52","author":"M Hatt","year":"2011","unstructured":"Hatt M, et al. Impact of tumor size and tracer uptake heterogeneity in <\u2009sup\u2009>\u200918\u2009F-FDG PET and CT Non\u2013Small cell lung Cancer tumor delineation. J Nucl Med. 2011;52(11):1690\u20137.","journal-title":"J Nucl Med"},{"issue":"4","key":"2677_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K. Intratumor heterogeneity: the Rosetta stone of therapy resistance. Cancer Cell. 2020;37(4):471\u201384.","journal-title":"Cancer Cell"},{"issue":"6","key":"2677_CR19","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/cas.15773","volume":"114","author":"H Wu","year":"2023","unstructured":"Wu H, et al. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma. Cancer Sci. 2023;114(6):2609\u201321.","journal-title":"Cancer Sci"},{"key":"2677_CR20","doi-asserted-by":"crossref","unstructured":"Osuka S et al. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma. J Clin Invest. 2021;131(6).","DOI":"10.1172\/JCI136098"},{"issue":"6","key":"2677_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","volume":"3","author":"F Davnall","year":"2012","unstructured":"Davnall F, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573\u201389.","journal-title":"Insights Imaging"},{"issue":"5","key":"2677_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jnci\/djae009","volume":"116","author":"M Othus","year":"2024","unstructured":"Othus M, et al. Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial. J Natl Cancer Inst. 2024;116(5):673\u201380.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2677_CR23","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18(3):e143\u201352.","journal-title":"Lancet Oncol"},{"key":"2677_CR24","doi-asserted-by":"crossref","unstructured":"Bach FR. Bolasso: model consistent Lasso estimation through the bootstrap, in Proceedings of the 25th international conference on Machine learning. 2008, Association for Computing Machinery: Helsinki, Finland. pp. 33\u201340.","DOI":"10.1145\/1390156.1390161"},{"issue":"4","key":"2677_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1467-9868.2010.00740.x","volume":"72","author":"N Meinshausen","year":"2010","unstructured":"Meinshausen N, B\u00fchlmann P. Stability selection. J Royal Stat Soc Ser B: Stat Methodol. 2010;72(4):417\u201373.","journal-title":"J Royal Stat Soc Ser B: Stat Methodol"},{"key":"2677_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-1-4612-4380-9_41","volume-title":"Breakthroughs in statistics: methodology and distribution","author":"B Efron","year":"1992","unstructured":"Efron B. Bootstrap methods: another look at the jackknife. Breakthroughs in statistics: methodology and distribution. New York: New York, NY: Springer; 1992. pp. 569\u201393. S. Kotz and N.L. Johnson, Editors."},{"issue":"5","key":"2677_CR27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.ijrobp.2003.09.075","volume":"58","author":"DTT Chua","year":"2004","unstructured":"Chua DTT, et al. Tumor volume is not an independent prognostic factor in early-stage nasopharyngeal carcinoma treated by radiotherapy alone. Int J Radiation Oncology*Biology*Physics. 2004;58(5):1437\u201344.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"3","key":"2677_CR28","doi-asserted-by":"publisher","first-page":"802","DOI":"10.21037\/tcr.2019.04.22","volume":"8","author":"W Ni","year":"2019","unstructured":"Ni W, et al. The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy. Translational Cancer Res. 2019;8(3):802\u201310.","journal-title":"Translational Cancer Res"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02677-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T12:37:26Z","timestamp":1749904646000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02677-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2677"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02677-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Fudan University Shanghai Cancer Center. Informed consent or a substitute for it was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}